Trials / Conditions / Stage III Lung Cancer

Stage III Lung Cancer

12 registered clinical trials studyying Stage III Lung Cancer — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC NCT06878274	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Terminated	Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors NCT06654245	Wake Forest University Health Sciences	N/A
Active Not Recruiting	A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources NCT06383988	Wake Forest University Health Sciences	N/A
Withdrawn	Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs NCT04985357	Travera Inc	—
Recruiting	Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients NCT06538038	PrECOG, LLC.	—
Terminated	Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer NCT06140407	Vanderbilt-Ingram Cancer Center	Phase 2
Recruiting	Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lun NCT05501665	Vanderbilt-Ingram Cancer Center	Phase 1 / Phase 2
Completed	Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748	Barbara Ann Karmanos Cancer Institute	N/A
Unknown	Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC NCT05641870	Parc de Salut Mar	—
Completed	Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668	Rutgers, The State University of New Jersey	N/A
Unknown	External ValidatIon Trial of ASTER Trial NCT01332240	Universitaire Ziekenhuizen KU Leuven	N/A
Completed	Lung Cancer Informational Study (LCIS) NCT00579215	Memorial Sloan Kettering Cancer Center	N/A